Back to today’s briefing

Story perspectives

Groundbreaking £42M Trial Launched for Prostate Cancer Screening

11/23/2025

45 11

Summary

Story summary

Prostate Cancer UK's TRANSFORM trial has launched, the largest prostate cancer screening study in over two decades.
The trial has a £42 million budget to test PSA blood tests and fast MRI scans for early detection.
It will recruit up to 300,000 men and address inequalities, notably Black men.
Funding comes from the National Institute for Health and Care Research (NIHR) and partners, and participants will shape future screening protocols.

1 of 1

Story summary

Prostate Cancer UK's TRANSFORM trial has launched, the largest prostate cancer screening study in over two decades.
The trial has a £42 million budget to test PSA blood tests and fast MRI scans for early detection.
It will recruit up to 300,000 men and address inequalities, notably Black men.
Funding comes from the National Institute for Health and Care Research (NIHR) and partners, and participants will shape future screening protocols.